ABSTRACT BACKGROUND Despite great advances in assisted reproductive technology,
poor ovarian response (POR) is still considered as one of the most challenging tasks in …

Advanced maternal age (AMA;> 35 year) is associated with a decline in both ovarian
reserve and oocyte competence. At present, no remedies are available to counteract the …

Many strategies have been proposed to manage poor responder patients, however, a
consensus upon which is the most beneficial has not been yet reached. DuoStim is the most …

Despite the fact that in the last two decades an enormous number of papers on the topic of
poor ovarian response have been published in the literature, so far it has been impossible to …

Secreted by the anterior pituitary gland, growth hormone (GH) is a peptide that plays a
critical role in regulating cell growth, development, and metabolism in multiple targeted …

Objective To study the effect of aging and granulosa cell growth hormone receptor (GHR)
expression, and the effect of growth hormone (GH) co-treatment during IVF on receptor …

Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …

Objective To evaluate the effectiveness of the addition of growth hormone (GH) to the
antagonist protocol in IVF/intracytoplasmic sperm injection cycles in poor responders …

Purpose To investigate whether growth hormone (GH) could improve pregnancy rates of
patients with thin endometrium by clinical study and laboratory experiments. Materials and …